FATIGUE AND OTHER SYMPTOMS FOLLOWING INTRAVENOUS ZOLEDRONATE THERAPY

FATIGUE AND OTHER SYMPTOMS FOLLOWING INTRAVENOUS ZOLEDRONATE THERAPY

Manylion Llyfryddiaeth
Prif Awduron:	Warburton, S, Jess, C, Javaid, M, Wass, J
Fformat:	Conference item
Cyhoeddwyd:	2009

Eitemau Tebyg

FAILURE OF P1NP SUPPRESSION FOLLOWING INTRAVENOUS ZOLEDRONATE: EFFECT OF DEFINITIONS, DOSE, VITAMIN D STATUS, AND BMI
gan: Warburton, S, et al.
Cyhoeddwyd: (2009)

SEVERE ADVERSE EVENT AFTER USE OF IV ZOLEDRONATE IN A PATIENT WITH MASTOCYTOSIS: A CASE REPORT
gan: Jess, C, et al.
Cyhoeddwyd: (2009)

Preserving hip bone mineral density following stroke using intravenous zoledronic acid: Findings from a 1 year randomised controlled trial
gan: Poole, K, et al.
Cyhoeddwyd: (2004)

Zoledronate prevents bone loss after stroke
gan: Poole, K, et al.
Cyhoeddwyd: (2006)

A single infusion of zoledronate prevents bone loss after stroke.
gan: Poole, K, et al.
Cyhoeddwyd: (2007)

Single dose of zoledronate prevents bone loss after acute stroke
gan: Poole, K, et al.
Cyhoeddwyd: (2006)

Bone structure and remodelling in stroke patients: early effects of zoledronate.
gan: Poole, K, et al.
Cyhoeddwyd: (2009)

The effects of zoledronate on iliac bone remodelling; a histomorphometric study in stroke patients
gan: Poole, K, et al.
Cyhoeddwyd: (2007)

OUTBREAK OF ACUTE HEPATITIS-C FOLLOWING INTRAVENOUS IMMUNOGLOBULIN THERAPY
gan: Healey, C, et al.
Cyhoeddwyd: (1994)

Yearly zoledronic acid in postmenopausal osteoporosis.
gan: Poole, K, et al.
Cyhoeddwyd: (2007)

Intra-arterial therapy following intravenous alteplase for severe ischemic stroke
gan: Hill, MD, et al.
Cyhoeddwyd: (2001)

Intravenous immunoglobulin therapy.
gan: Chapel, H
Cyhoeddwyd: (1996)

The symptom of generalised fatigue
gan: Sharpe, M
Cyhoeddwyd: (2006)

The effects of zoledronate on iliac bone remodelling in stroke patients
gan: Poole, K, et al.
Cyhoeddwyd: (2007)

Home intravenous immunoglobulin therapy.
gan: Chapel, H, et al.
Cyhoeddwyd: (1988)

The homing of prostate cancer to bone in vivo is modulated by Zoledronic acid
gan: Reeves, K, et al.
Cyhoeddwyd: (2011)

Interpretation of symptoms in chronic fatigue syndrome.
gan: Dendy, C, et al.
Cyhoeddwyd: (2001)

A single injection of zoledronic acid may prevent bone loss after stroke: Planned interim analysis of a randomised trial
gan: Poole, K, et al.
Cyhoeddwyd: (2004)

Zoledronic acid prevents the development of myeloma bone disease and increases survival
gan: Shipman, C, et al.
Cyhoeddwyd: (2002)

Delayed recovery of leg fatigue symptoms following a maximal exercise session in people with multiple sclerosis.
gan: Dawes, H, et al.
Cyhoeddwyd: (2014)

The effect of Zoledronate treatment timing on lumbar and caudal vertebrae in ovariectomized rats
gan: Ruchelsman, Michal (Michal Aliza)
Cyhoeddwyd: (2008)

Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy.
gan: Healey, C, et al.
Cyhoeddwyd: (1996)

Alendronate and ibandronate affect osteoclast formation and size differently from risedronate and zoledronate
gan: Mabilleau, G, et al.
Cyhoeddwyd: (2011)

Crystal structures and molecular interactions of risedronate and zoledronate with human farnesyl diphosphate synthase
gan: Kavanagh, K, et al.
Cyhoeddwyd: (2006)

Zoledronic Acid Inhibits the Capacity of Myeloid-Immune Suppressor Cells in Myeloma to Form Osteoclasts.
gan: Zhuang, J, et al.
Cyhoeddwyd: (2008)

The pharmacokinetics of L-tryptophan following its intravenous and oral administration.
gan: Green, A, et al.
Cyhoeddwyd: (1985)

The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel.
gan: Jagdev, S, et al.
Cyhoeddwyd: (2001)

The effectiveness of behavioural and cognitive behavioural therapies for insomnia on depressive and fatigue symptoms: a systematic review and network meta-analysis
gan: Ballesio, A, et al.
Cyhoeddwyd: (2017)

Intraperitoneal chemotherapy following refractory intravenous route in advanced ovarian cancer.
gan: Shafiee MN,, et al.
Cyhoeddwyd: (2013)

Changes to sleep patterns and insomnia symptoms following cognitive behavioural therapy for anxiety disorders in adolescents
gan: Sukiennik, A, et al.
Cyhoeddwyd: (2024)

Fundamentals of metal fatigue analysis/
gan: 345261 Bannantine, Julie A., et al.
Cyhoeddwyd: (1990)

The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy
gan: Bjorkander, J, et al.
Cyhoeddwyd: (2000)

Understanding the role of intravenous iron to treat anaemia following critical care
gan: Shah, A
Cyhoeddwyd: (2021)

Fatigue is not a specific symptom in patients with primary biliary cirrhosis.
gan: Björnsson, E, et al.
Cyhoeddwyd: (2005)

Do more people recover from chronic fatigue syndrome with cognitive behaviour therapy or graded exercise therapy than with other treatments?
gan: Sharpe, M, et al.
Cyhoeddwyd: (2017)

Following dislocation patterning during fatigue
gan: Irastorza-Landa, A, et al.
Cyhoeddwyd: (2016)

Safe intravenous antibiotic therapy at home: experience of a UK based programme.
gan: Kayley, J, et al.
Cyhoeddwyd: (1996)

Zoledronic acid prevents the development of osteolytic bone disease and increases survival in a murine model of multiple myeloma
gan: Croucher, P, et al.
Cyhoeddwyd: (2002)

Pharmacokinetics of ampicillin trihydrate following intravenous administration to water deprived Nubian goats
gan: Elsheikh, Hatim Ali, et al.
Cyhoeddwyd: (1998)

Acute intravenous--intra-arterial revascularization therapy for severe ischemic stroke.
gan: Hill, MD, et al.
Cyhoeddwyd: (2002)